. 2014 Feb 5;10(4):995–1007. doi: 10.4161/hv.27739

Table 1. Meningococcal quadrivalent vaccines¹⁸^,¹⁰¹^,¹⁴⁵.

Formulation	Type	Trade name	Manufacturer	Licensed year	Age group	Dose (s)	Serogroups
MPV-4	Polysaccharide	Menomune	Sanofi Pasteur	1981	≥2 y	1	A, C, W, and Y
MPV-4	Polysaccharide	Mencevax	GlaxoSmithKline		≥2 y	1
MenACWY-DT	Conjugate	Menactra	Sanofi Pasteur	2005	11–55 y	1
				2007	2–10 y	1
				2010	9–23 mo	2
MenACWY-CRM	Conjugate	Menveo	Novartis	2010	11–55 y	1
				2011	2–10 y	1
				2013	2–23 mo	4 (if 2–6 mo) 2 (if 7–23 mo)
MenACWY-TT	Conjugate	Nimenrix	GlaxoSmithKline	2012	≥12 mo	1

Table 1. Meningococcal quadrivalent vaccines18,101,145.